HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that may progress to invasive cancer. Identification of factors that predict recurrence and distinguish DCIS from invasive recurrence would facilitate treatment recommendations. We examined the prognostic value of ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304413/
https://www.ncbi.nlm.nih.gov/pubmed/22361634
http://dx.doi.org/10.1038/bjc.2012.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304413/
https://www.ncbi.nlm.nih.gov/pubmed/22361634
http://dx.doi.org/10.1038/bjc.2012.41

Ejemplares similares